Women prescribed penicillins, erythromycins, and cephalosporins for bacterial infections during their first trimester may be reassured that these ntibacterial agents are not significantly associated with birth defects, new research shows.
Women prescribed penicillins, erythromycins, and cephalosporins for bacterial infections during their first trimester may be reassured that these antibacterial agents are not significantly associated with birth defects, according to researchers at the Centers for Disease Control and Prevention and the University of Arkansas for Medical Sciences in Little Rock.
For women prescribed sulfonamides and nitrofurantoins during pregnancy, the news is less rosy.
The population-based, multisite, case-controlled study compared 13,155 women whose pregnancies were affected by 1 of more than 30 types of birth defects with 4,941 matched controls. Reported use of antibiotics increased during the first trimester. Of these, sulfonamides were associated with anencephaly, hypoplastic left heart syndrome, coarctation of the aorta, choanal atresia, transverse limb deficiency, and diaphragmatic hernia. Nitrofurantonins were associated with anophthalmia or microphthalmos, septal defects, and cleft lip or palate. However, infants of women treated with erythromycins, penicillins, cephalosporins, and quinolones had minimal risk of birth defects.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More